Levetiracetam Treatment-Associated Acute Rhabdomyolysis in an Adolescent
JOURNAL OF PEDIATRIC INTENSIVE CARE, vol.9, no.2, pp.139-140, 2020 (ESCI)
- Publication Type: Article / Article
- Volume: 9 Issue: 2
- Publication Date: 2020
- Doi Number: 10.1055/s-0039-1700951
- Journal Name: JOURNAL OF PEDIATRIC INTENSIVE CARE
- Journal Indexes: Emerging Sources Citation Index (ESCI), EMBASE
- Page Numbers: pp.139-140
- Çukurova University Affiliated: Yes
Abstract
Etiology of rhabdomyolysis includes hereditary muscle enzyme deficiencies, trauma, viral infections, excessive exercise, hypothyroidism, and medications such as colchicine, lithium, and statins. Several studies have reported that various antiepileptic drugs may induce rhabdomyolysis. Levetiracetam is one of the antiepileptic drugs implicated in the etiology of rhabdomyolysis. Herein, we present a case of rhabdomyolysis in an adolescent treated with levetiracetam. We wanted to draw attention to the increasing trend of levetiracetam-associated rhabdomyolysis frequency in pediatric patients.